Cognition Therapeutics to Participate in 37th Annual Piper Sandler Healthcare Conference
Cognition Therapeutics to Participate in 37th Annual Piper Sandler Healthcare Conference GlobeNewswire November 20, 2025 PURCHASE, N.Y., Nov. 20, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage company developing product candidates designed to treat neurodegenerative disorders, announced that the Company's president and CEO, Lisa Ricciardi will participate in an “unplugged” fireside […]